Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

OBJECTIVE: Comorbidities are common in multiple sclerosis (MS) and adversely affect health outcomes. However, the effect of comorbidity on treatment decisions in MS remains unknown. We aimed to examine the effects of comorbidity on initiation of injectable disease-modifying therapies (DMTs) and on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tingting, Tremlett, Helen, Leung, Stella, Zhu, Feng, Kingwell, Elaine, Fisk, John D., Bhan, Virender, Campbell, Trudy L., Stadnyk, Karen, Yu, B. Nancy, Marrie, Ruth Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826339/
https://www.ncbi.nlm.nih.gov/pubmed/26944268
http://dx.doi.org/10.1212/WNL.0000000000002543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826339/
https://www.ncbi.nlm.nih.gov/pubmed/26944268
http://dx.doi.org/10.1212/WNL.0000000000002543

Ejemplares similares